Early Breast Cancer: LHRH Agonists Show Considerable Promise

Courtesy ScienceDaily  Fri, 10/10/2008 - 11:45

Women who have had early stage breast cancer surgically removed, and whose tumor cells are stimulated by the hormone estrogen, can benefit from taking luteinizing hormone releasing hormone antagonists, a Cochrane systematic review has concluded.

This medication may be taken alone or alongside the use of tamoxifen.

Tags:

 

More related items

New Predictive Tool Can Help Determine Treatment Of...
A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with early stage breast cancer -- a low PEPI (preoperative endocrine prognostic index) score...

Bone Drug Could Help Prevent The Spread Of Breast...
Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to new research. Bones are common sites for the spread, or...

Scientists Identify 'Gatekeepers' Of Breast Cancer...
Scientists have made a significant discovery that clarifies a previously poorly understood key event in the progression of breast cancer. The research highlights the importance of the...

Backyard Livestock: Raising Good, Natural Food for...
This popular and widely praised book describes everything you need to know about selecting and raising small livestock.Long the primary reference for anyone who keeps animals as a sustainable...

The Complete Guide to Asperger's Syndrome
"The Complete Guide to Asperger's Syndrome" is the definitive handbook for anyone affected by Asperger's syndrome (AS). It brings together a wealth of information on all aspects of the...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com